Critical research on biomarkers: What's new?

Intensive Care Medicine

Volumn 39, Issue 10, 2013, Pages 1824-1828

  Legrand, Matthieu ^a,b,c   Januzzi, James L ^d   Mebazaa, Alexandre ^a,b,c  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CHROMOGRANIN A; CREATININE; CYSTATIN C; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; LIVER TYPE FATTY ACID BINDING PROTEIN; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SODIUM; TROPONIN; UNCLASSIFIED DRUG; UREA;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ARTICLE; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; HUMAN; KIDNEY DYSFUNCTION; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; SODIUM URINE LEVEL; UREA BLOOD LEVEL;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; CRITICAL CARE; HEART DISEASES; HUMANS; KIDNEY DISEASES; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84884595886     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-3008-7     Document Type: Article

References (19)

1. Mårtensson J, Bell M, Oldner A, Xu S, Venge P, Martling CR (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333-1340. doi: 10.1007/s00134-010-1887-4
2. Valette X, Savary B, Nowoczyn M et al (2013) Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness. Intensive Care Med 39:857-865. doi: 10.1007/s00134-013-2826-y
3. Legrand M, Collet C, Gayat E et al (2013) Accuracy of urine NGAL commercial assays in critically ill patients. Intensive Care Med 39:541-542. doi: 10.1007/s00134-012-2788-5
4. Mårtensson J, Xu S, Bell M, Martling CR, Venge P (2012) Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin Chim Acta 413:1661-1667. doi: 10.1016/j.cca.2012.05.010
5. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W (2013) Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 28:254-273. doi: 10.1093/ndt/gfs380
6. Royakkers AANM, Korevaar JC, van Suijlen JDE et al (2011) Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intens Care Med 37:493-501. doi: 10.1007/s00134-010-2087-y
7. Orenes-Piñero E, Manzano-Fernández S, López-Cuenca A, Marín F, Valdés M, Januzzi JL (2013) β-trace protein: from GFR marker to cardiovascular risk predictor. Clin J Am Soc Nephrol 8:873-881. doi: 10.2215/CJN.08870812
8. Maisel AS, Mueller C, Fitzgerald R et al (2011) Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL evaLuation along with B-type NaTriuretic peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail 13:846-851. doi: 10.1093/eurjhf/hfr087
9. Mårtensson J, Bell M, Oldner A, Xu S, Venge P, Martling C-R (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333-1340. doi: 10.1007/s00134-010-1887-4
10. Nejat M, Pickering JW, Devarajan P et al (2012) Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 81:1254-1262. doi: 10.1038/ki.2012.23
11. Vaidya VS, Ozer JS, Dieterle F et al (2010) Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 28:478-485. doi: 10.1038/nbt.1623
12. Haaf P, Drexler B, Reichlin T et al (2012) High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac non coronary artery disease. Circulation 126:31-40. doi: 10.1161/CIRCULATIONAHA. 112.100867
13. Bajwa EK, Boyce PD, Januzzi JL, Gong MN, Thompson BT, Christiani DC (2007) Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome. Crit Care Med 35:2484-2490
14. Ouanes-Besbes L, Dachraoui F, Ouanes I et al (2012) NT-proBNP levels at spontaneous breathing trial help in the prediction of post-extubation respiratory distress. Intensive Care Med 38:788-795. doi: 10.1007/s00134-012- 2524-1
15. Mekontso Dessap A, Roche-Campo F, Kouatchet A et al (2012) Natriuretic peptide-driven fluid management during ventilator weaning: a randomized controlled trial. Am J Respir Crit Care Med 186:1256-1263. doi: 10.1164/rccm.201205-0939OC
16. Januzzi JL Jr (2013) ST2 as a cardiovascular risk biomarker: from the bench to the bedside. J Cardiovasc Transl Res. doi: 10.1007/s12265-013-9459-y
17. Bajwa E, Volk J, Christiani D et al (2013) Prognostic and diagnostic value of plasma soluble ST2 concentrations in acute lung injury. Crit Care Med (in press)
18. Røsjø H, Nygård S, Kaukonen K-M et al (2012) Prognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study. Intensive Care Med 38:820-829. doi: 10.1007/s00134-012-2546-8
19. Bossuyt PM, Reitsma JR, Bruns DE et al (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 138:W1-W12